Abstract:To sustain metabolism, intracellular ATP concentration must be regulated within an appropriate range. This coordination is achieved through the function of the AMP-activated protein kinase (AMPK), a cellular "fuel gauge" that is expressed in essentially all eukaryotic cells as heterotrimeric complexes containing catalytic $\alpha$ subunits and regulatory $\beta$ and $\gamma$ subunits. When cellular energy status has been compromised, AMPK is activated by increases in AMP:ATP or ADP:ATP ratios and acts to restore energy homeostasis by stimulating energy production via catabolic pathways while decreasing non-essential energy-consuming pathways. Although the primary function of AMPK is to regulate energy homeostasis at a cell-autonomous level, in multicellular organisms, the AMPK system has evolved to interact with hormones to regulate energy intake and expenditure at the whole body level. Thus, AMPK functions as a signaling hub, coordinating anabolic and catabolic pathways to balance nutrient supply with energy demand at both the cellular and whole-body levels. AMPK is activated by various metabolic stresses such as ischemia or hypoxia or glucose deprivation and has both acute and long-term effects on metabolic pathways and key cellular functions. In addition, AMPK appears to be a major sensor of energy demand in exercising muscle and acts both as a multitask gatekeeper and an energy regulator in skeletal muscle. Acute activation of AMPK has been shown to promote glucose transport and fatty acid oxidation while suppressing glycogen synthase activity and protein synthesis. Chronic activation of AMPK induces a shift in muscle fiber type composition, reduces markers of muscle degeneration and enhances muscle oxidative capacity potentially by stimulating mitochondrial biogenesis. Furthermore, recent evidence demonstrates that AMPK may not only regulate metabolism during exercise but also in the recovery phase. AMPK acts as a molecular transducer between exercise and insulin signaling and is necessary for the ability of prior contraction/exercise to increase muscle insulin sensitivity. Based on these observations, drugs that activate AMPK might be expected to be useful in the treatment of metabolic disorders and insulin resistance in various conditions.

AMP-activated protein kinase: the current landscape for drug development

Promise and challenges for direct small molecule AMPK activators

AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules

New insights into activation and function of the AMPK

AMPK signalling in health and disease

AMPK as a Therapeutic Target for Treating Metabolic Diseases

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance

Computer-aided drug design for AMP-activated protein kinase activators.

Targeting of AMP-activated protein kinase: prospects for computer-aided drug design

AMPK inhibition in health and disease

Dissecting the Role of AMP-activated Protein Kinase in Human Diseases

The Energy Sensor AMPK: Adaptations to Exercise, Nutritional and Hormonal Signals

AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention

Natural activators of AMPK signaling: potential role in the management of type-2 diabetes

AMPK As A Target in Rare Diseases

Emerging Role of cAMP/AMPK Signaling

Structural and Biochemical Insights into the Allosteric Activation Mechanism of AMP‐activated Protein Kinase

Post-Translational Modifications of the Energy Guardian AMP-Activated Protein Kinase